Aurora Investment Counsel Fulgent Genetics, Inc. Transaction History

Aurora Investment Counsel

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 22, 2023	SELL	$26.74 - $40.81 $31,847 - $48,604	-1,191 Reduced 12.53%	8,312 $222,000
Q2 2023 Aug 14, 2023	SELL	$28.52 - $40.7 $6,787 - $9,686	-238 Reduced 2.44%	9,503 $351,000
Q1 2023 Jun 06, 2023	BUY	$29.39 - $36.27 $277,353 - $342,279	9,437 Added 3104.28%	9,741 $304,000
Q1 2023 Jun 05, 2023	SELL	$29.39 - $36.27 $317,617 - $391,969	-10,807 Reduced 97.26%	304 $9,000
Q4 2022 Feb 03, 2023	SELL	$29.23 - $40.28 $270,231 - $372,388	-9,245 Reduced 45.42%	11,111 $330,000
Q3 2022 Nov 23, 2022	BUY	$37.92 - $63.74 $39,891 - $67,054	1,052 Added 5.45%	20,356 $776,000
Q2 2022 Aug 12, 2022	SELL	$47.98 - $62.75 $38,431 - $50,262	-801 Reduced 3.98%	19,304 $1.21 Million
Q2 2022 Aug 12, 2022	BUY	$47.98 - $62.75 $38,431 - $50,262	801 Added 4.15%	20,105 $1.1 Million
Q1 2022 May 23, 2022	BUY	$49.85 - $96.11 $208,821 - $402,604	4,189 Added 27.71%	19,304 $1.21 Million
Q4 2021 Feb 07, 2022	BUY	$77.3 - $105.0 $85,957 - $116,760	1,112 Added 7.94%	15,115 $1.52 Million
Q3 2021 Nov 17, 2021	BUY	$74.87 - $110.87 $1.05 Million - $1.55 Million	14,003 New	14,003 $1.26 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Aurora Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Aurora Investment Counsel with notifications on news.